
Thermo Fisher Scientific Influenza A HA Recombinant Human Monoclonal Antibody (CR6261)
Influenza A HA 단백질을 인식하는 인간 단일클론 항체로, 대부분의 그룹 1 인플루엔자 바이러스에 결합. ELISA 및 중화시험 등 다양한 연구용으로 사용 가능. HEK293 세포에서 발현된 재조합 항체이며, Protein A로 정제된 액상 형태. 연구용으로만 사용.
- 판매단위
- pk
카탈로그
1개 옵션 · 카탈로그 번호를 클릭하면 복사됩니다Thermo Fisher Scientific · Thermo Fisher Scientific Influenza A HA Recombinant Human Monoclonal Antibody (CR6261)
Thermo Fisher Scientific Influenza A HA Recombinant Human Monoclonal Antibody (CR6261)
Applications
- ELISA (ELISA): Assay-dependent
- Neutralization (Neu): Assay-dependent
- Functional Assay (Functional): Assay-dependent
Product Specifications
| 항목 | 내용 |
|---|---|
| Species Reactivity | Virus |
| Host / Isotype | Human / IgG1, kappa |
| Expression System | HEK293 cells |
| Class | Recombinant Monoclonal |
| Type | Antibody |
| Clone | CR6261 |
| Immunogen | The original antibody was isolated using phage display from the IgM+ memory B cells of a healthy individual vaccinated against influenza. |
| Conjugate | Unconjugated |
| Form | Liquid |
| Concentration | 1 mg/mL |
| Purification | Protein A |
| Storage Buffer | PBS |
| Contains | 0.02% ProClin 300 |
| Storage Conditions | Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
| Shipping Conditions | Wet ice |
Product Specific Information
This antibody binds hemagglutinin of most group 1 influenza viruses. CR6261 recognizes a highly conserved helical region in the membrane-proximal stem of HA1/HA2.
Target Information
Infectious diseases remain a major global health issue, accounting for a large portion of mortality worldwide. Influenza research continues to be critical as new strains emerge due to viral gene reassortment. This antibody aids in detecting infectious disease agents, facilitating studies on influenza and other viral pathogens.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Thermo Fisher Scientific 상품 둘러보기
전체보기문의
0개 · 배송·재고 문의는 실시간 상담이 빠릅니다아직 등록된 문의가 없어요.
